Latest filing published 25 Jun 2026 for Kymera Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Noah Goodman: trading record in brief
Noah Goodman discloses dealings in Kymera Therapeutics, Inc. to SEC (Form 4). We count 11 filings; the first trade dates from 8 April 2025 and the latest from 25 June 2026.
Sales make up the whole of the open-market record (7 sales, €1.4M). The rest of the record consists of 2 share grants and 2 option exercises. 2026 to date brings no purchases and 7 sales.
The record was last updated on 25 June 2026 with an open-market sale (€240k) in Kymera Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Noah Goodman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 sharesCommon StockSEC:0001193125-26-283139:0
- 2,500 sharesCommon StockSEC:0001193125-26-283139:1
- 2,500 sharesCommon StockSEC:0001193125-26-283139:2
- 1,347 shares@ US$90.000.0012% mcap100.0% of flowCommon StockSEC:0001193125-26-159539:0
- 2,500 shares@ US$21.055.5% of flowCommon StockSEC:0001193125-26-151393:0
- 3,094 shares@ US$86.61828.2% of flowCommon StockSEC:0001193125-26-151393:1
- 2,670 shares@ US$87.110924.5% of flowCommon StockSEC:0001193125-26-151393:2
- 2,500 shares@ US$89.0023.4% of flowCommon StockSEC:0001193125-26-151393:3
- 2,000 shares@ US$87.350.0018% mcap18.4% of flowCommon StockSEC:0001193125-26-151393:4
- 9,225 shares0Common StockSEC:0001193125-26-091984:0
- 50,000 shares0Common StockSEC:0000950170-25-052310:0
11 of 11 declarations
